Kinex News
Back to headlines
April 23, 2007
Kinex Pharmaceuticals Presents at International Cancer Meeting
Kinex scientists presented recent data on the discovery and development of KXO1, at the American Association for Cancer Research Annual Meeting in Los Angeles, on April 16, 2007. KXO1 is a non-ATP competitive Src kinase inhibitor that will enter Phase 1 clinical trials for oncology during the second half of 2007.
The presentation entitled “Potent and Selective in vitro and in vivo Inhibition of Tumor Proliferation by KXO1, a Novel Non-ATP Competitive Src Inhibitor", was enthusiastically received by the international community of cancer research scientists.